CSIMarket
 
Dyax Corp  (DYAX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Dyax Growth Comparisons

Select each growth Category to receive further Information



DYAX Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 12.44 % 13.39 % 3.93 % 1.28 %
Q / Q Revenue Growth (Q3 MRQ) -6.23 % 0.51 % -4.22 % 5.89 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 36.44 % 12.75 % 13.46 % %
Seq. Revenue Growth (for 12 months ending Q3 TTM) 2.89 % -9.25 % -18.25 % -15.34 %
Revenue 5 Year Average Growth - 17.64 % 13.52 % 12.15 %


DYAX's Growth Comparisons in III. Quarter 2015




Dyax's 12.44% year on year Revenue increase in the third quarter 2015 to 25 millions, marks slow-down from Dyax's growth trends, and competes unfavorably to the 13.39% rise in the Medical Laboratories industry, but beating the 3.93% growth in the Healthcare sector. Above the average sales gains in the Healthcare and in the Medical Laboratories industry as well, helped to elevate overall market growth to 1.28%.

Top-line fell by -6.23% from the second quarter. Average annual sales growth for Dyax is %, while S & P 500's average yearly sales increase is 12.15%, including only Businesses with the third quarter 2015 financial results.


Growth Rates of DYAX's Income in the third quarter 2015


DYAX Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) - 51.19 % -10.96 % -6.54 %
Seq. Operating Income Change (Q3 MRQ) - 42.11 % -19.14 % 6.54 %
Y / Y Operating Income Growth (Q3 TTM) - 8.96 % 7.26 % 14.04 %
Seq. Operating Income Growth (Q3 TTM) - -8 % -19.11 % -22.01 %
Operating Income 5 Year Avg. Change - 5.95 % 16.52 % 20.5 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) - 57.58 % 8.04 % -16.12 %
Seq. Income from Cont. Ops. Change (Q3 MRQ) - 60.74 % -0.19 % -0.83 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) - 13.22 % -3.06 % -9.7 %
Seq. Income from Cont. Ops. Change (Q3 TTM) - -11.62 % -24.3 % -21.06 %
Income from Cont. Ops. 5 Year Avg. Change - 2.55 % 7.07 % 23.59 %

DYAX Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) - 58.46 % 5.74 % -14.4 %
Q / Q Net Income Growth (Q3 MRQ) - 60.73 % -1.13 % 1.71 %
Y / Y Net Income Change (Q3 TTM) - 11.91 % -1.58 % -11.03 %
Seq. Net Income Change (Q3 TTM) - -11.88 % -26.71 % -22.27 %
Net Income 5 Year Avg. Growth - 2.61 % 5.07 % 24.05 %

DYAX's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) - 96.08 % 8.04 % -16.12 %
Seq. EPS from Cont. Ops. Change (Q3 MRQ) - 55.21 % -0.19 % -0.83 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) - -39.79 % - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) - -12.21 % -9.25 % -18.56 %
EPS from Cont. Ops. 5 Year Avg. Growth - -46.28 % 7.07 % 23.59 %



DYAX EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) - 97.17 % 5.74 % -14.4 %
Q / Q EPS Net Growth (Q3 MRQ) - 55.2 % -1.13 % 1.71 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - -50.08 % - -8.3 %
Seq. EPS Net Change (for 12 months ending Q3 TTM) - -13.65 % - -22.13 %
EPS Net 5 Year Avg. Change - 2.61 % 5.07 % 24.05 %



Dyax reported bottom-line of $ -0.08 in the third quarter, compare to $ -0.01 in the same quarter a year ago. Medical Laboratories industry grew by 97.17%, while Healthcare sector increased by 5.74%, and overall market declined by -14.4%.

the bottom-line fell by -6.23% from the second quarter. Average annual income per share growth for Dyax is %, while S & P 500's average yearly income per share increase is 24.05%, including only Businesses with the third quarter 2015 earnings.

DYAX Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) - -5.44 % -94.49 % -
Seq. Free Cash Flow Change (Q3 MRQ) - -1.95 % -93.55 % -
Y / Y Free Cash Flow Change (Q3 TTM) - 40.54 % 17.1 % 0.87 %
Seq. Free Cash Flow Change (Q3 TTM) - 13.14 % -1.99 % 9.63 %
Free Cash Flow 5 Year Avg. Change - 7.98 % 6.46 % 8.68 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - 160.68 % - -
Seq. Net Cash Flow Change (Q3 MRQ) - - - -
Y / Y Net Cash Flow Change (Q3 TTM) - 37.76 % - -
Seq. Net Cash Flow Change (Q3 TTM) - 42.55 % - -23.31 %
Net Cash Flow 5 Year Avg. Change - -7.83 % -18.16 % -15.22 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) 40.73 % 47.05 % -73.52 % -95.88 %
Seq. Capital Expenditures Change (Q3 MRQ) -56.76 % 13.74 % -75.27 % -94.91 %
Y / Y Capital Expenditures Change (Q3 TTM) 239.07 % 69.18 % 49.92 % -4.14 %
Seq. Capital Expenditures Change (Q3 TTM) 8.32 % 3.51 % 0.38 % -5.45 %
Capital Expenditures 5 Year Avg. Change - 12.68 % 5 % 9.04 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com